[{"NetIncomeLoss_1_Q3_USD":-36078000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":26766687.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":71248846.0,"CommitmentsAndContingencies_0_Q3_USD":null,"InterestIncomeOther_3_Q3_USD":3104000.0,"InterestIncomeOther_1_Q3_USD":534000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":9680000.0,"PreferredStockValueOutstanding_0_Q3_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":176000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":275178000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts_1_Q3_USD":34707000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":12231000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":55762000.0,"Depreciation_3_Q3_USD":2637000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":425293000.0,"PaymentsToAcquireInvestments_3_Q3_USD":140097000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":2649713.0,"AssetsCurrent_0_Q3_USD":721850000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7635597.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":7635597.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":442000.0,"CommonStockSharesIssued_0_Q3_shares":89977603.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":154184000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":158092000.0,"Assets_0_Q3_USD":751681000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":23045000.0,"Investments_0_Q3_USD":154184000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":24376000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":5.71,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":3664000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":5934000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":3096000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":529000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q3_USD":715570000.0,"PaymentOfFinancingAndStockIssuanceCosts_3_Q3_USD":2507000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":426453000.0,"RestrictedCash_0_Q3_USD":878000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":4.42,"IncomeLossFromContinuingOperations_3_Q3_USD":-265477000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-265477000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-213867000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_3_Q3_USD":-149000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q3_USD":-455000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-87837000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-36533000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-1693000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":559282000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":22484000.0,"Liabilities_0_Q3_USD":38156000.0,"IncomeLossFromContinuingOperations_1_Q3_USD":-213867000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":67739000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-149000.0,"UnrealizedGainLossOnInvestments_1_Q3_USD":-455000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":154008000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":430000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":7461779.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":1696242.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-439504000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":517328000.0,"CommonStockSharesOutstanding_0_Q3_shares":89803785.0,"PreferredStockDividendsAndOtherAdjustments_3_Q3_USD":-177789000.0,"PreferredStockDividendsAndOtherAdjustments_1_Q3_USD":-177789000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":176000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1867000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":11929000.0,"LiabilitiesCurrent_0_Q3_USD":15666000.0,"AccountsPayableCurrent_0_Q3_USD":4553000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":560160000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":8384000.0,"AdditionalPaidInCapital_0_Q3_USD":1152763000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":283275.0,"ProceedsFromSaleAndMaturityOfOtherInvestments_3_Q3_USD":300056000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":64744000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6579000.0,"NetIncomeLoss_3_Q3_USD":-87688000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-67217000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-455000.0,"StockholdersEquity_0_Q3_USD":713525000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-9.92,"ShareBasedCompensation_3_Q3_USD":17416000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":22374000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":4.91,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":1160000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"CommonStockValueOutstanding_0_Q3_USD":90000.0,"OperatingIncomeLoss_3_Q3_USD":-90784000.0,"OperatingIncomeLoss_1_Q3_USD":-36607000.0,"OtherNonoperatingExpense_3_Q3_USD":8000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-3.0,"OtherNonoperatingExpense_1_Q3_USD":5000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":7.67,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":4.09,"LiabilitiesAndStockholdersEquity_0_Q3_USD":751681000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":17416000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":11929000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":210835.0,"StockIssuedDuringPeriodValueTreasuryStockReissued_1_Q3_USD":-177789000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1433000.0,"OperatingExpenses_3_Q3_USD":90784000.0,"OperatingExpenses_1_Q3_USD":36607000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":427800000.0,"ConversionOfStockAmountConverted1_3_Q3_USD":715508000.0,"Ticker":"RLAY","CIK":"1812364","name":"RELAY THERAPEUTICS, INC.","OfficialName":"Relay Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3171086334.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]